|
시장보고서
상품코드
1789375
세계의 복합 주사제 시장 : 분자 유형별, 치료 용도별, 제품 유형별, 포장 유형별, 투여 경로별, 연령층별, 유통 채널별, 최종 사용자별, 지역별(2025-2032년)Complex Injectable Market, By Molecule Type, By Therapeutic Application, By Product Type, By Packaging Type, By Route of Administration, By Age Group, By Distribution Channel, By End User, By Geography |
||||||
세계의 복합 주사제 시장은 2025년 261억 1,000만 달러로 추정되고, 2032년까지 465억 달러에 이를 것으로 예측되며, 예측 기간 중 연평균 성장률(CAGR) 8.6%로 성장할 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 시장 규모(2025년) | 261억 1,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측기간 CAGR(2025-2032년) | 8.60% | 예측 금액(2032년) | 465억 달러 |
세계의 복합 주사제 시장은 제약 업계에서 급속히 발전하고 있는 분야이며, 특별한 제조, 취급, 투여 프로토콜을 필요로 하는 고급 약물전달 시스템을 포함하고 있습니다. 복합 주사제에는 리포좀, 마이크로스피어, 에멀젼, 현탁액 및 기타 고급 제제와 같은 복잡한 제조 공정과 독특한 물리화학적 특성으로 인해 쉽게 복제할 수 없는 다양한 제품이 포함됩니다. 이러한 제품은 기존 주사제에 비해 치료 효과 향상, 환자 컴플라이언스 개선, 표적 약물 전달 기능을 제공하기 때문에 최근 몇 년 동안 큰 지원을 받고 있습니다.
이 시장은 브랜드화된 복잡한 제네릭 의약품과 혁신적인 생물학적 제제를 모두 포함하며 종양학, 면역학, 심장병학, 중추신경계 질환과 같은 중요한 치료 분야에 기여하고 있습니다. 만성 질환 증가, 맞춤형 의료에 대한 수요 증가, 세계 의료 지출 증가 등이 시장의 급격한 성장에 기여하고 있습니다. 게다가 일부 블록버스터 복합 주사제의 특허 만료는 제네릭 제조업체에게 유리한 기회를 만들어내고, 약물전달 시스템의 기술 진보는 이 분야의 기술 혁신을 촉진하고, 복합 주사제를 현대의 의료 제공 시스템에 필수적인 요소로 하고 있습니다.
시장 역학
세계 복합 주사제 시장은 주로 성장 궤도를 추진하는 몇 가지 매력적인 요인에 의해 견인되고 있습니다. 암, 당뇨병, 자가면역질환, 심혈관질환 등 만성질환 증가로 뛰어난 생물학적 이용능력과 표적 전달 메커니즘을 통해 복합 주사제가 제공할 수 있는 고급 치료 솔루션에 대한 수요가 높아지고 있습니다. 수많은 블록버스터 복합 주사제의 특허 절벽은 제네릭 제조업체가 바이오시밀러 및 제네릭 의약품으로 시장에 진입할 수 있는 큰 기회를 열어 시장 접근성을 확대하고 의료 비용을 절감하고 있습니다. 나노기술을 구사한 제제, 서방형 메커니즘, 정밀의료에의 접근 등 약물전달 시스템의 기술적 진보가 기술 혁신을 촉진하여 새로운 치료의 가능성을 창출하고 있습니다.
세계 고령화의 진전과 더불어, 신흥 시장에서의 의료 지출 증가와 의료 인프라의 정비가 시장의 확대를 더욱 추진하고 있습니다. 그러나 시장은 대규모 임상시험과 복잡한 승인 프로세스를 요구하는 엄격한 규제 요건, 개발 비용 및 시장 개척 기간의 대폭적인 증가 등 현저한 억제요인에 직면하고 있습니다. 복잡한 주사제에는 고도로 정교한 제조 공정이 요구되기 때문에 특수한 시설이나 설비에의 대액의 설비 투자가 필요해, 신규 진입의 장벽이 되고 있습니다. 또한 이러한 제품은 기술적으로 복잡하기 때문에 생물학적 동등성 달성과 일관된 품질 확보가 과제가 되는 한편, 제제 개발이나 약사에 관한 전문 지식이 제한되어 시장 진입이 제한됩니다. 이러한 과제에도 불구하고 의료 디지털화의 진전, 의약품 섹터가 성장하는 신흥국 시장에서의 사업 확대, 혁신기업과 제네릭 제조업체와의 전략적 제휴, 신규 약물전달 기술이나 맞춤형 의료 어프로치에 초점을 맞춘 지속적인 연구 개발 등 기회가 풍부합니다.
이 보고서의 주요 특징
- 본 보고서는 세계의 복합주사제 시장을 상세하게 분석하여 2024년을 기준 연도로 한 예측기간(2025-2032년) 시장 규모 및 CAGR을 제공합니다.
- 또한 각 부문의 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
- 또한 시장 성장 촉진요인 및 억제요인과 기회, 신제품의 출시와 승인, 시장 동향, 지역별 전망, 주요기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 세계 복합 주사제 시장의 주요 기업 프로파일은 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 다음 매개 변수를 기반으로 게시됩니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전술에 대한 충분한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- '세계의 복합 주사제 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
- 이해관계자는 세계의 복합 주사제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
- 분석 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 성장 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- Porter's Five Forces 분석
- 합병과 인수 시나리오
- 업계 동향
제4장 세계의 복합 주사제 시장 : 분자 유형별(2020-2032년)
- 소분자
- 생물학적 제형 베이스
제5장 세계의 복합 주사제 시장 : 치료 용도별(2020-2032년)
- 종양
- 자가면역질환
- 감염증
- 대사 장애
- 혈액 질환
- 신경질환
- 안과
- 피부과
- 심혈관 질환
- 기타(희소질환)
제6장 세계의 복합 주사제 시장 : 제품 유형별(2020-2032년)
- 단일클론항체
- 펩티드와 단백질
- 항생제
- 화학요법제
- 호르몬
- 혈액 인자
- 유전자 치료 제품
- 세포 치료 제품
- 기타(올리고뉴클레오티드)
제7장 세계의 복합 주사제 시장 : 포장 유형별(2020-2032년)
- 바이알
- 프리필드 주사기
- 앰풀
- 카트리지
- 기타(점적 백)
제8장 세계의 복합 주사제 시장 : 투여 경로별(2020-2032년)
- 정맥내(IV)
- 근육내(IM)
- 피하(SC)
- 척수내
- 관절 내
- 기타 비경구 경로(피내)
제9장 세계의 복합 주사제 시장 : 연령층별(2020-2032년)
- 소아
- 성인
- 고령자
제10장 세계의 복합 주사제 시장 : 유통 채널별(2020-2032년)
- 병원 약국
- 온라인 약국
- 소매 약국
제11장 세계의 복합 주사제 시장 : 최종 사용자별(2020-2032년)
- 병원
- 전문 클리닉
- 외래수술센터(ASC)
- 재택치료
제12장 세계의 복합 주사제 시장 : 지역별(2020-2032년)
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제13장 경쟁 구도
- Pfizer Inc
- Novartis AG
- Hoffmann-La Roche Ltd
- Johnson & Johnson
- Merck & Co., Inc
- Sanofi SA
- GlaxoSmithKline plc
- AstraZeneca PLC
- Eli Lilly and Company
- Amgen Inc
- AbbVie Inc
- Bristol Myers Squibb
- Takeda Pharmaceutical Co. Ltd
- Biogen Inc
- Gilead Sciences Inc
제14장 애널리스트의 제안
- 「운명의 고리」
- 애널리스트의 견해
- Coherent Opportunity Map(COM)
제15장 참고문헌과 조사방법
- 참고문헌
- 분석 방법
- Coherent Market Insights에 대해
Complex Injectable Market is estimated to be valued at USD 26.11 Bn in 2025 and is expected to reach USD 46.50 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 26.11 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 8.60% | 2032 Value Projection: | USD 46.50 Bn |
The global complex injectable market represents a rapidly evolving segment of the pharmaceutical industry, encompassing sophisticated drug delivery systems that require specialized manufacturing, handling, and administration protocols. Complex injectables include a diverse range of products such as liposomes, microspheres, emulsions, suspensions, and other advanced formulations that cannot be easily replicated due to their intricate manufacturing processes and unique physicochemical properties. These products have gained significant traction in recent years as they offer enhanced therapeutic efficacy, improved patient compliance, and targeted drug delivery capabilities compared to conventional injectable formulations.
The market encompasses both branded complex generics and innovative biologics, serving critical therapeutic areas including oncology, immunology, cardiology, and central nervous system disorders. The increasing prevalence of chronic diseases, growing demand for personalized medicine, and rising healthcare expenditure globally have contributed to the substantial growth of this market. Additionally, the patent expiration of several blockbuster complex injectable drugs has created lucrative opportunities for generic manufacturers, while technological advancements in drug delivery systems continue to drive innovation in this space, making complex injectables an essential component of modern healthcare delivery systems.
Market Dynamics
The global complex injectable market is primarily driven by several compelling factors that continue to propel its growth trajectory. The increasing prevalence of chronic diseases such as cancer, diabetes, autoimmune disorders, and cardiovascular diseases has created substantial demand for advanced therapeutic solutions that complex injectables can provide through their superior bioavailability and targeted delivery mechanisms. Patent cliffs of numerous blockbuster complex injectable drugs have opened significant opportunities for generic manufacturers to enter the market with biosimilar and generic versions, thereby expanding market accessibility and reducing healthcare costs. Technological advancements in drug delivery systems, including nanotechnology-based formulations, sustained-release mechanisms, and precision medicine approaches, are driving innovation and creating new therapeutic possibilities.
The growing aging population worldwide, coupled with rising healthcare expenditure and improved healthcare infrastructure in emerging markets, further supports market expansion. However, the market faces notable restraints including stringent regulatory requirements that demand extensive clinical trials and complex approval processes, significantly increasing development costs and time-to-market. The highly sophisticated manufacturing processes required for complex injectables necessitate substantial capital investments in specialized facilities and equipment, creating barriers for new entrants. Additionally, the technical complexity of these products poses challenges in achieving bioequivalence and ensuring consistent quality, while limited expertise in formulation development and regulatory affairs restricts market participation. Despite these challenges, opportunities abound through increasing healthcare digitalization, expansion in emerging markets with growing pharmaceutical sectors, strategic partnerships between innovator companies and generic manufacturers, and continuous research and development efforts focused on novel drug delivery technologies and personalized medicine approaches.
Key Features of the Study
- This report provides in-depth analysis of the global complex injectable market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global complex injectable market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer Inc, Novartis AG, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Merck & Co., Inc, Sanofi SA, GlaxoSmithKline plc, AstraZeneca PLC, Eli Lilly and Company, Amgen Inc, AbbVie Inc, Bristol Myers Squibb, Takeda Pharmaceutical Co. Ltd, Biogen Inc, and Gilead Sciences Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global complex injectable market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global complex injectable market
Market Segmentation
- Molecule Type Insights (Revenue, USD Bn, 2020 - 2032)
- Small Molecule
- Biologics-Based
- Therapeutic Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Metabolic Disorders
- Hematological Disorders
- Neurological Disorders
- Ophthalmology
- Dermatology
- Cardiovascular Diseases
- Others (Rare Diseases)
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Monoclonal Antibodies
- Peptides and Proteins
- Antibiotics
- Chemotherapy Agents
- Hormones
- Blood Factors
- Gene Therapy Products
- Cell Therapy Products
- Others (Oligonucleotides)
- Packaging Type Insights (Revenue, USD Bn, 2020 - 2032)
- Vials
- Prefilled Syringes
- Ampoules
- Cartridges
- Others (IV Bags)
- Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Intravenous (IV)
- Intramuscular (IM)
- Subcutaneous (SC)
- Intrathecal
- Intra-articular
- Other Parenteral Routes (Intradermal)
- Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric
- Adult
- Geriatric
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers (ASCs)
- Home Healthcare Settings
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc
- Novartis AG
- Hoffmann-La Roche Ltd
- Johnson & Johnson
- Merck & Co., Inc
- Sanofi SA
- GlaxoSmithKline plc
- AstraZeneca PLC
- Eli Lilly and Company
- Amgen Inc
- AbbVie Inc
- Bristol Myers Squibb
- Takeda Pharmaceutical Co. Ltd
- Biogen Inc
- Gilead Sciences Inc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Complex Injectable Market, By Molecule Type
- Global Complex Injectable Market, By Therapeutic Application
- Global Complex Injectable Market, By Product Type
- Global Complex Injectable Market, By Packaging Type
- Global Complex Injectable Market, By Route of Administration
- Global Complex Injectable Market, By Age Group
- Global Complex Injectable Market, By Distribution Channel
- Global Complex Injectable Market, By End User
- Global Complex Injectable Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Complex Injectable Market, By Molecule Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Small Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biologics-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Complex Injectable Market, By Therapeutic Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hematological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Rare Diseases)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Complex Injectable Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Peptides and Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chemotherapy Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hormones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Blood Factors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gene Therapy Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cell Therapy Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Oligonucleotides)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Complex Injectable Market, By Packaging Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ampoules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cartridges
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (IV Bags)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Complex Injectable Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Intravenous (IV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intramuscular (IM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Subcutaneous (SC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intrathecal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intra-articular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other Parenteral Routes (Intradermal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Complex Injectable Market, By Age Group, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Complex Injectable Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
11. Global Complex Injectable Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers (ASCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Home Healthcare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
12. Global Complex Injectable Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
13. Competitive Landscape
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Co. Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biogen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gilead Sciences Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
14. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
15. References and Research Methodology
- References
- Research Methodology
- About us
